Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.

Hansen, Dennis Lund; Maquet, Julien; Lafaurie, Margaux; Möller, Sören; Berentsen, Sigbjørn; Frederiksen, Henrik; Moulis, Guillaume; Gaist, David.

Br J Haematol ; 204(3): 1072-1081, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38098244

2.

Sutimlimab in Cold Agglutinin Disease.

Röth, Alexander; Barcellini, Wilma; D'Sa, Shirley; Miyakawa, Yoshitaka; Broome, Catherine M; Michel, Marc; Kuter, David J; Jilma, Bernd; Tvedt, Tor H A; Fruebis, Joachim; Jiang, Xiaoyu; Lin, Stella; Reuter, Caroline; Morales-Arias, Jaime; Hobbs, William; Berentsen, Sigbjørn.

N Engl J Med ; 384(14): 1323-1334, 2021 04 08.

Artículo en Inglés | MEDLINE | ID: mdl-33826820

3.

Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease.

Malecka, Agnieszka; Østlie, Ingunn; Trøen, Gunhild; Malecki, Jedrzej; Delabie, Jan; Tierens, Anne; Munthe, Ludvig A; Berentsen, Sigbjørn; Tjønnfjord, Geir E.

Clin Exp Immunol ; 216(1): 45-54, 2024 03 12.

Artículo en Inglés | MEDLINE | ID: mdl-38133636

4.

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.

Röth, Alexander; Berentsen, Sigbjørn; Barcellini, Wilma; D'Sa, Shirley; Jilma, Bernd; Michel, Marc; Weitz, Ilene C; Yamaguchi, Masaki; Nishimura, Jun-Ichi; Vos, Josephine M I; Storek, Michael; Wong, Nancy; Patel, Parija; Jiang, Xiaoyu; Vagge, Deepthi S; Wardecki, Marek; Shafer, Frank; Lee, Michelle; Broome, Catherine M.

Blood ; 140(9): 980-991, 2022 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-35687757

5.

Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy.

Berentsen, Sigbjørn.

Curr Oncol Rep ; 2024 Jun 14.

Artículo en Inglés | MEDLINE | ID: mdl-38874820

6.

How I treat cold agglutinin disease.

Berentsen, Sigbjørn.

Blood ; 137(10): 1295-1303, 2021 03 11.

Artículo en Inglés | MEDLINE | ID: mdl-33512410

7.

Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.

Röth, Alexander; Barcellini, Wilma; D'Sa, Shirley; Miyakawa, Yoshitaka; Broome, Catherine M; Michel, Marc; Kuter, David J; Jilma, Bernd; Tvedt, Tor Henrik Anderson; Weitz, Ilene C; Yoo, Ronnie; Jayawardene, Deepthi; Vagge, Deepthi S; Kralova, Katarina; Shafer, Frank; WardÈ©cki, Marek; Lee, Michelle; Berentsen, Sigbjørn.

Am J Hematol ; 98(8): 1246-1253, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-37246953

8.

Cold agglutinin disease revisited: a multinational, observational study of 232 patients.

Berentsen, Sigbjørn; Barcellini, Wilma; D'Sa, Shirley; Randen, Ulla; Tvedt, Tor Henrik Anderson; Fattizzo, Bruno; Haukås, Einar; Kell, Megan; Brudevold, Robert; Dahm, Anders E A; Dalgaard, Jakob; Frøen, Hege; Hallstensen, Randi Fykse; Jæger, Pernille H; Hjorth-Hansen, Henrik; Malecka, Agnieszka; Oksman, Markku; Rolke, Jürgen; Sekhar, Mallika; Sørbø, Jon Hjalmar; Tjønnfjord, Eirik; Tsykunova, Galina; Tjønnfjord, Geir E.

Blood ; 136(4): 480-488, 2020 07 23.

Artículo en Inglés | MEDLINE | ID: mdl-32374875

9.

Cold agglutinin disease: where do we stand, and where are we going?

Berentsen, Sigbjørn; Malecka, Agnieszka; Randen, Ulla; Tjønnfjord, Geir E.

Clin Adv Hematol Oncol ; 18(1): 35-44, 2020 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-32511221

10.

Autoimmune Hemolytic Anemias.

Berentsen, Sigbjørn; Barcellini, Wilma.

N Engl J Med ; 385(15): 1407-1419, 2021 10 07.

Artículo en Inglés | MEDLINE | ID: mdl-34614331

11.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

Berentsen, Sigbjørn; Randen, Ulla; Oksman, Markku; Birgens, Henrik; Tvedt, Tor Henrik Anderson; Dalgaard, Jakob; Galteland, Eivind; Haukås, Einar; Brudevold, Robert; Sørbø, Jon Hjalmar; Næss, Inger Anne; Malecka, Agnieszka; Tjønnfjord, Geir E.

Blood ; 130(4): 537-541, 2017 07 27.

Artículo en Inglés | MEDLINE | ID: mdl-28533306

12.

How I manage patients with cold agglutinin disease.

Berentsen, Sigbjørn.

Br J Haematol ; 181(3): 320-330, 2018 05.

Artículo en Inglés | MEDLINE | ID: mdl-29363757

13.

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.

Jalink, Marit; Berentsen, Sigbjørn; Castillo, Jorge J; Treon, Steven P; Cruijsen, Marjan; Fattizzo, Bruno; Cassin, Ramona; Fotiou, Despina; Kastritis, Efstathios; De Haas, Masja; Oosten, Liesbeth E M; Frederiksen, Henrik; Patriarca, Andrea; D'Sa, Shirley; Vos, Josephine M I.

Blood ; 138(20): 2002-2005, 2021 11 18.

Artículo en Inglés | MEDLINE | ID: mdl-34293088

14.

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.

Roth, Alexander; Barcellini, Wilma; D'Sa, Shirley; Miyakawa, Yoshitaka; Broome, Catherine M; Michel, Marc; Kuter, David J; Jilma, Bernd; Tvedt, Tor Henrik Anderson; Weitz, Ilene C; Patel, Parija; Jiang, Xiaoyu; Reuter, Caroline; Su, Jun; Shafer, Frank; Lee, Michelle; Berentsen, Sigbjorn.

Haematologica ; 107(7): 1698-1702, 2022 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-35172561

15.

Mortality in cold agglutinin disease shows seasonal pattern.

Hansen, Dennis Lund; Möller, Sören; Berentsen, Sigbjørn; Frederiksen, Henrik.

Transfusion ; 62(7): 1460-1461, 2022 07.

Artículo en Inglés | MEDLINE | ID: mdl-35531960

16.

Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.

Tvedt, Tor Henrik A; Steien, Egil; Øvrebø, Bente; Haaverstad, Rune; Hobbs, William; Wardecki, Marek; Tjønnfjord, Geir Erland; Berentsen, Sigbjørn Andreas.

Am J Hematol ; 97(2): E51-E54, 2022 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-34778998

17.

Complement, cold agglutinins, and therapy.

Berentsen, Sigbjørn.

Blood ; 123(26): 4010-2, 2014 Jun 26.

Artículo en Inglés | MEDLINE | ID: mdl-24970929

18.

Cold agglutinins: fending off the attack.

Berentsen, Sigbjørn.

Blood ; 133(9): 885-886, 2019 02 28.

Artículo en Inglés | MEDLINE | ID: mdl-30819775

19.

Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy.

Hansen, Dennis Lund; Berentsen, Sigbjørn; Fattizzo, Bruno; Hansen, Pernille Lund; Barcellini, Wilma; Frederiksen, Henrik.

Am J Hematol ; 96(7): E262-E265, 2021 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-33864697

20.

The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels.

Malecka, Agnieszka; Trøen, Gunhild; Delabie, Jan; Malecki, Jedrzej; Østlie, Ingunn; Tierens, Anne; Randen, Ulla; Berentsen, Sigbjørn; Tjønnfjord, Geir E.

Am J Hematol ; 96(8): E279-E283, 2021 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-33891703

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.

Sutimlimab in Cold Agglutinin Disease.

Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease.

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.

Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy.

How I treat cold agglutinin disease.

Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.

Cold agglutinin disease revisited: a multinational, observational study of 232 patients.

Cold agglutinin disease: where do we stand, and where are we going?

Autoimmune Hemolytic Anemias.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

How I manage patients with cold agglutinin disease.

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.

Mortality in cold agglutinin disease shows seasonal pattern.

Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.

Complement, cold agglutinins, and therapy.

Cold agglutinins: fending off the attack.

Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy.

The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels.